#atezolizumab
Live, measured metrics for the hashtag #atezolizumab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #atezolizumab
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mas.to (Mastodon public tags API) · fetched 2026-10-18 07:05 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · mas.to (Mastodon public search API) · fetched 2026-10-18 07:05 UTCNo related tags with measured usage found for #atezolizumab.
Live pulse
measured · mas.to (Mastodon tag timeline) · fetched 2026-10-18 07:05 UTCEverything below is measured over the latest 7 public posts (spanning ~27252 hours).
Posting hours (UTC)
Languages: English (4) · Italian (2) · Spanish (1)
Avg boosts / post: 0.1
Top of the latest posts
https://www.europesays.com/it/722710/ Tumore del colon, l’immunoterapia arriva dopo la chirurgia: la FDA approva una nuova cura per pazienti selezionati #ArnoldD #atezolizumab #atomic #dMMR #FDA #FOLFOX #IT #Italia #Italy #OuFS #Science #Sc
https://www.europesays.com/ch/142079/ Excalipoint Therapeutics Announces Clinical Trial Collaboration with Roche to Evaluate EXP011 in DLL3‑Expressing Solid Tumors #atezolizumab #ClinicalCollaboration #NeuroendocrineTumors #Roche #SmallCell
Natera’s Signatera Wins Japan PMDA Approval as Bladder Cancer CDx Natera NTRA recently announced that its Signatera test received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency… #EuropeSays #Japan #JP #atezolizu
What “atezolizumab” means
WikipediaAtezolizumab, sold under the brand name Tecentriq among others, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma, but discontinued for use in triple-negative breast cancer (TNBC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
“Atezolizumab” on Wikipedia (CC BY-SA) →#atezolizumab across platforms
every network with a public tag surfaceFollow #atezolizumab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/atezolizumab